Colony Group’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $1.45M | Sell |
89,926
-2,827
| -3% | -$45.6K | 0.02% | 381 |
|
|
2023
Q2 | $3.85M | Buy |
92,753
+88,821
| +2,259% | +$3.69M | 0.05% | 261 |
|
|
2023
Q1 | $236K | Sell |
3,932
-99,831
| -96% | -$5.99M | ﹤0.01% | 711 |
|
|
2022
Q4 | $7.61M | Buy |
103,763
+11,970
| +13% | +$878K | 0.11% | 184 |
|
|
2022
Q3 | $6.97M | Sell |
91,793
-303
| -0.3% | -$23K | 0.12% | 163 |
|
|
2022
Q2 | $6.4M | Buy |
92,096
+4,347
| +5% | +$302K | 0.11% | 175 |
|
|
2022
Q1 | $7.27M | Buy |
87,749
+5,181
| +6% | +$429K | 0.11% | 167 |
|
|
2021
Q4 | $6.2M | Buy |
82,568
+786
| +1% | +$59K | 0.11% | 160 |
|
|
2021
Q3 | $9.5M | Sell |
81,782
-6,651
| -8% | -$773K | 0.18% | 103 |
|
|
2021
Q2 | $19.6M | Sell |
88,433
-5,773
| -6% | -$1.28M | 0.39% | 69 |
|
|
2021
Q1 | $12.5M | Sell |
94,206
-4,164
| -4% | -$550K | 0.26% | 88 |
|
|
2020
Q4 | $17M | Sell |
98,370
-3,088
| -3% | -$534K | 0.39% | 67 |
|
|
2020
Q3 | $11.3M | Sell |
101,458
-4,825
| -5% | -$537K | 0.29% | 82 |
|
|
2020
Q2 | $6.3M | Sell |
106,283
-4,326
| -4% | -$257K | 0.18% | 114 |
|
|
2020
Q1 | $7.45M | Sell |
110,609
-4,370
| -4% | -$294K | 0.24% | 108 |
|
|
2019
Q4 | $9.69M | Sell |
114,979
-3,708
| -3% | -$312K | 0.24% | 110 |
|
|
2019
Q3 | $8.88M | Sell |
118,687
-19,940
| -14% | -$1.49M | 0.28% | 99 |
|
|
2019
Q2 | $8.77M | Buy |
+138,627
| New | +$8.77M | 0.28% | 97 |
|